The Role of Arachidonic Acid Metabolites in Gastrointestinal Homeostasis
- 1 January 1987
- journal article
- Published by Springer Nature in Drugs
- Vol. 33 (Supplement) , 38-46
- https://doi.org/10.2165/00003495-198700331-00007
Abstract
Metabolites of arachidonic acid have a broad range of physiological functions in the gastrointestinal tract, and seem to be involved in certain disturbances of gastrointestinal integrity and function. Prostaglandins inhibit gastric acid secretion, apparently via an adenylate cyclaselinked receptor, and also stimulate bicarbonate and mucus production by alternative mechanisms. These are all beneficial in treating gastroduodenal ulceration. Moreover, clinical studies have revealed deficient prostaglandin synthesis in the gastric and duodenal mucosa of patients with gastrointestinal ulcers, which suggests that endogenous prostaglandins have a protective role in the gastrointestinal tract. In animal studies, prostaglandin analogues have been shown to protect the gastric mucosa from damage induced by various potent irritants, and this protection seems to involve the deeper layers of the mucosa as well as the epithelium. Indeed, misoprostol and other prostaglandin analogues have proved therapeutically effective in treating gastroduodenal ulceration. Prostaglandins also influence intestinal motility and fluid movement. Prostaglandin E derivatives generally relax circular smooth muscle, contract longitudinal smooth muscle and increase fluid secretion into the intestinal lumen. As a result of these effects, prostaglandins may cause diarrhoea. There is also evidence that prostaglandin synthesis is increased in patients with diarrhoea. Finally, it has been reported that tissue concentrations of prostaglandins are increased in patients with ulcerative colitis, but it is unclear if this is a primary cause, or secondary event. Significantly greater conversion of arachidonic acid to its metabolites was recorded in the mucosa of patients with inflammatory bowel disease compared with the mucosa of healthy subjects. This included a substantial increase in the concentration of leukotriene B4. Moreover, the drugs sulphasalazine and 5-amino-salicylic acid, which are used for the treatment of ulcerative colitis, markedly decreased the synthesis of leukotriene B4 and other products of arachidonic acid metabolism. Thus, prostaglandins, in particular, have important effects on gastrointestinal function. They may have a beneficial effect in the treatment of gastric or duodenal ulcers. However, they can cause intestinal secretion and diarrhoea, and may play a pathogenetic role in ulcerative colitis.Keywords
This publication has 15 references indexed in Scilit:
- Prostaglandin E1 (Misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healingDigestive Diseases and Sciences, 1986
- A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjectsDigestive Diseases and Sciences, 1986
- Duodenal bicarbonate secretion in humansDigestive Diseases and Sciences, 1986
- Prostaglandins and histological changes in the gastric mucosaDigestive Diseases and Sciences, 1985
- Effect of 16,16-Dimethyl Prostaglandin E2 on the Surface Hydrophobicity of Aspirin-Treated Canine Gastric MucosaGastroenterology, 1985
- Enhanced Synthesis of Leukotriene B4 by Colonic Mucosa in Inflammatory Bowel DiseaseGastroenterology, 1984
- Prostanoid Synthesis by Cultured Gastric and Duodenal Mucosa: Possible Role in the Pathogenesis of Duodenal UlcerScandinavian Journal of Gastroenterology, 1983
- PREVENTION OF ASPIRIN-INDUCED DROP IN GASTRIC POTENTIAL DIFFERENCE WITH 16, 16-DIMETHYL-PROSTAGLANDIN E2The Lancet, 1981
- Comparison of Serum Salicylate Levels and Gastro-Intestinal Blood Loss Between Salsalate (Disalcid) and other Forms of SalicylatesScandinavian Journal of Rheumatology, 1981
- Cytoprotection by prostaglandinsGastroenterology, 1979